Optimize Financial Inc Buys Shares of 19,832 AdaptHealth Corp. (NASDAQ:AHCO)

Optimize Financial Inc bought a new position in shares of AdaptHealth Corp. (NASDAQ:AHCO) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,832 shares of the company’s stock, valued at approximately $189,000.

Other large investors have also added to or reduced their stakes in the company. Assetmark Inc. bought a new stake in AdaptHealth during the fourth quarter valued at $28,000. Blue Trust Inc. lifted its position in AdaptHealth by 24.1% during the fourth quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after purchasing an additional 1,115 shares during the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock worth $121,000 after buying an additional 1,690 shares in the last quarter. KLP Kapitalforvaltning AS bought a new position in shares of AdaptHealth in the 4th quarter worth $169,000. Finally, Proficio Capital Partners LLC purchased a new stake in shares of AdaptHealth during the 4th quarter valued at $181,000. Institutional investors own 82.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on AHCO shares. Truist Financial increased their target price on AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. UBS Group decreased their price objective on AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Royal Bank of Canada upped their target price on AdaptHealth from $11.00 to $14.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 26th. Canaccord Genuity Group lifted their price target on shares of AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. Finally, Robert W. Baird upped their price objective on shares of AdaptHealth from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $13.80.

AdaptHealth Stock Performance

NASDAQ:AHCO opened at $8.66 on Monday. The company has a debt-to-equity ratio of 1.34, a quick ratio of 1.00 and a current ratio of 1.24. AdaptHealth Corp. has a fifty-two week low of $8.35 and a fifty-two week high of $11.90. The firm has a market cap of $1.17 billion, a PE ratio of -5.25, a price-to-earnings-growth ratio of 1.08 and a beta of 1.44. The business has a 50 day moving average price of $9.86 and a 200-day moving average price of $10.07.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.